Patient selection
Renal denervation for hypertension
The Symplicity™ blood pressure procedure can help a wide range of patients you see in daily clinical practice.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Renal denervation for hypertension
The Symplicity™ blood pressure procedure can help a wide range of patients you see in daily clinical practice.
Patients who may be candidates for the Symplicity blood pressure procedure tend to fall into one of three groups. Typically, these patients are open to a balanced conversation about the procedure that takes their preferences into account.
Patients who take multiple anti-hypertensive medications and are rigorously adherent — yet still not able to control their blood pressure (BP) — are often ready for a different treatment approach.2
The more medications patients take, the lower their adherence.2-4 Non- adherence doubles when patients move from two to three pills.2-4 These factors may explain why nearly half of patients become non-adherent within one year.5
Factors driving preference for the Symplicity blood pressure procedure tend to be associated with how clearly the patient understands the benefits of blood pressure reduction. These factors include:
A growing number of expert position and consensus statements from medical societies worldwide are shaping patient selection criteria for renal denervation, including the Symplicity blood pressure procedure.
A position paper from the European Society of Hypertension recommends renal denervation as an evidence-based treatment option for a wide range of patients.1
Jose Garcia-Donaire, M.D., reviews global consensus statements that can help identify the right patients for renal denervation, including the Symplicity blood pressure procedure.
Professor Isabella Sudano, PhD, discusses which patients are best suited for the Symplicity blood pressure procedure, including how to incorporate patient preference.
Prof. Isabella Sudano - (06:40)
A photo of Prof. Isabella Sudano, a leading expert in renal denervation (RDN), discusses which types of patients are best suited for the RDN procedure.
More information (see more)
Less information (see less)
This three-part series from Radcliffe Medical Education covers practical applications of RDN guidelines for patients with resistant hypertension. CME accredited.
Patients with hypertension may see the Symplicity
blood pressure procedure differently than physicians,
and many may prefer a procedural approach even if
they are not taking anti-hypertensive medications.2
Explore resources for introducing the Symplicity blood pressure procedure to your community.
Educate your patients about the risks of hypertension and why the Symplicity blood pressure procedure may be the right choice.
Schmieder R, Mahfoud F, Mancia G, et al. European Society of Hypertension position paper on renal denervation 2021. J Hypertens. 2021;39(9):1733-1741.
Schmieder R, Kandzari D, Wang TD, et. al. Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension. J Hypertens. 2020. Doi:10.1097/HJH.0000000000002592.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-3104. https://doi.org/10.1093/eurheartj/ehy339.
Schmieder RE, Mahfoud F, Azizi M, et al. European Society of Hypertension position paper on renal denervation 2018. J Hypertens. 2018;36(10):2042-2048.
Bruno RM, Taddei S, Borghi C, et al. Italian Society of Arterial Hypertension (SIIA) position paper on the role of renal denervation in the management of the difficult-to-treat hypertensive patient. High Blood Press Cardiovasc Prev. 2020;27:109-117.